Modélisation de la reprise de l'élimination du VHC après la pandémie de COVID-19 aux États-Unis : voies pour reprendre les progrès
Summary As of 2019, the United States (US) was not on track to achieve targets for elimination, due to increasing incidence and treatment barriers. In 2020, the COVID-19 pandemic disrupted HCV services globally and in the US. As healthcare services normalize, there is an urgent need to reassess progress and evaluate scenarios that restore a […]